Overview

Ceftaroline in the Treatment of Bone and Joint Infections

Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.
Phase:
Phase 4
Details
Lead Sponsor:
Orlando Health, Inc.
Collaborator:
Forest Laboratories
Treatments:
Ceftaroline fosamil
Cephalosporins
Methicillin